Translating Research into Action in a Challenged Region ...Translating Research into Action in a...

14
1 Translating Research into Action in a Challenged Region: Programs to Stem the Tide of HIV in Eastern Europe and Central Asia Jack A. DeHovitz, MD, MPH Distinguished Service Professor, Department of Medicine Director, New York State International Training and Research Program SUNY Downstate Medical Center Brooklyn, NY March 16, 2018 Consortium of Universities for Global Health

Transcript of Translating Research into Action in a Challenged Region ...Translating Research into Action in a...

  • 1

    Translating Research into Action in a Challenged Region: Programs to Stem the

    Tide of HIV in Eastern Europe and Central Asia

    Jack A. DeHovitz, MD, MPHDistinguished Service Professor, Department of Medicine

    Director, New York State International Training and Research ProgramSUNY Downstate Medical Center

    Brooklyn, NY

    March 16, 2018

    Consortium of Universities for Global Health

    http://www.downstate.edu/gallery/logos/DMSLogo-Final-cmyk.eps

  • Antecedents of Estonian EpidemicIncidence of HBV/HCV Infections and Absolute Number of

    HIV Infections in Estonia, 1988-2002

    Uuskula, A. et al Int J Inf Dis. 2002; 6(1): 23-7.

  • Source: David Guttenfelder/Associated Press, 2005

  • Source:

    Major Drug Trafficking Routes

    Russia

    Map: GoogleEarth

    China

    Afghanistan

    Almaty

    UNODC, 2008

  • Reported routes of HIV transmission*, byEuropean sub-region, 2015

    7

    100%

    90%

    80%

    70%

    60%

    50%

    40%

    30%

    20%

    10%

    0%

    Region West Centre* Among those with known route of transmission

    East

    Source: ECDC/WHO (2016). HIV/AIDS Surveillance in Europe, 2015

    Heterosexual

    Sex betweenmen

    Injecting druguse

    Mother to child

  • Estimated new HIV infections are decreasing globally

    1,400,000

    1,600,000

    1,800,000

    2,000,000

    2,200,000

    2,400,000

    2,600,000

    2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

    Num

    bero

    fnew

    diag

    nose

    s(gl

    obal

    )

    Year of diagnosis

    Source: ECDC/WHO (2016). HIV/AIDS Surveillance in Europe, 2015. UNAIDS/WHO global estimates.

    GlobalGlobal

  • Estimated new HIV infections are decreasing globally, but increasing in the WHO European Region

    0

    40,000

    1,600,00020,000

    60,000

    80,000

    120,000

    2,200,000

    100,000

    140,000

    160,000

    180,000

    1,400,000

    1,800,000

    2,000,000

    2,400,000

    2,600,000

    2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

    Num

    bern

    ewdi

    agno

    ses(

    Euro

    pean

    regi

    on)

    Num

    bero

    fnew

    diag

    nose

    s(gl

    obal

    )

    Year of diagnosis

    Global

    WHOEuropean Region

    Source: ECDC/WHO (2016). HIV/AIDS Surveillance in Europe, 2015. UNAIDS/WHO global estimates.

  • Estimated new HIV infections are decreasing globally, but increasing in the WHO European Region

    0

    20,000

    40,000

    60,000

    80,000

    120,000

    2,200,000

    100,000

    140,000

    160,000

    180,000

    1,400,000

    1,600,000

    1,800,000

    2,000,000

    2,400,000

    2,600,000

    2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

    WHOEuropean Region

    Global

    East

    West

    Centre

    Source: ECDC/WHO (2016). HIV/AIDS Surveillance in Europe, 2015. UNAIDS/WHO global estimates.

  • Global Progress Towards 90-90-90

  • Progress Towards 90-90-90 in Eastern Europe and Central Asia

  • Availability of Needle & Syringe Exchange Programmes (NSP) and Opioid Substitution Therapy (OST) in EECA

    Both NSP and OST

    NSP only

    HRI. The Global State of Harm Reduction 2016

  • Number of Needles/Syringes Distributed per Person per Year in EECA

    Number of needles/syringes distributed per PWID

    UNAIDS AIDSInfo. http://aidsinfo.unaids.org/

    Recommended Level

    http://aidsinfo.unaids.org/Chart1

    Tajikistan

    Estonia

    Kyrgyzstan

    Kazakhstan

    Lithuania

    Georgia

    Moldova

    Latvia

    Armenia

    Ukraine

    Uzbekistan

    Belarus

    Azerbaijan

    Series 1

    345.4

    230

    152.8

    119.7

    101.8

    90.9

    87.5

    84.4

    72.1

    71.3

    62.3

    41.1

    34.4

    Sheet1

    Series 1Series 2Series 3

    Tajikistan345.42.42

    Estonia2301.83

    Kyrgyzstan152.84.42

    Kazakhstan119.72.85

    Lithuania101.8

    Georgia90.9

    Moldova87.5

    Latvia84.4

    Armenia72.1

    Ukraine71.3

    Uzbekistan62.3

    Belarus41.1

    Azerbaijan34.4

  • Percentage of People with Opioid Dependence Use Receiving OST,

    2015

    UNAIDS Prevention Gap Report, 2016

  • New York State International Training and Research Program 25 year Fogarty HIV Research Training focused

    on Eastern Europe and Central Asia Linked closely with multiple NY State based

    training efforts Over 110 graduates with a 93% return rate Over 1100 publications subsequent to training

    with >50 extramural grants Currently focused on implementation science

    training14

    Translating Research into Action in a Challenged Region: Programs to Stem the Tide of HIV in Eastern Europe and Central AsiaAntecedents of Estonian EpidemicSlide Number 3Slide Number 4Reported routes of HIV transmission*, by�European sub-region, 2015Estimated new HIV infections are decreasing globallySlide Number 7Slide Number 8Global Progress Towards 90-90-90Progress Towards 90-90-90 in Eastern Europe and Central AsiaAvailability of Needle & Syringe Exchange Programmes (NSP) and Opioid Substitution Therapy (OST) in EECANumber of Needles/Syringes Distributed per Person per Year in EECAPercentage of People with Opioid Dependence Use Receiving OST, 2015New York State International Training and Research Program